RIPK1 and cancer: Also, conflicting results have been generated in the study on the impact of RIPK1 inhibitor on metastasis, showing GNE684 had no effect as compared to PK68.265,354 Therefore, different RIPK1 inhibitors have shown varying results and reinforced a nebulous role of RIPK1 in cancer, thus, require further study.